Clostridium difficile--more difficult than ever

N Engl J Med. 2008 Oct 30;359(18):1932-40. doi: 10.1056/NEJMra0707500.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Antibodies, Bacterial / blood
  • Bacterial Toxins / metabolism
  • Clostridium Infections* / epidemiology
  • Clostridium Infections* / therapy
  • Clostridium Infections* / virology
  • Clostridium difficile / immunology
  • Clostridium difficile / pathogenicity*
  • Clostridium difficile / physiology
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Disease Outbreaks
  • Enterocolitis, Pseudomembranous
  • Humans
  • Immunoglobulin G / blood
  • Immunotherapy
  • Incidence
  • Probiotics / therapeutic use
  • Secondary Prevention
  • United States / epidemiology

Substances

  • Anti-Bacterial Agents
  • Antibodies, Bacterial
  • Bacterial Toxins
  • Immunoglobulin G